Real-time PCR, Digital PCR, and End-point PCR Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Consumables & Reagents, Software & Services); By Technology; By Application; By Region; Segment Forecast, 2024 - 2032
The global Real-time PCR, Digital PCR, And End-point PCR market size is expected to reach USD 10.96 billion by 2032, according to a new study by Polaris Market Research. The report “Real-time PCR, Digital PCR, and End-point PCR Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Consumables & Reagents, Software & Services); By Technology; By Application; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Continuous technological advancements in PCR platforms are propelling significant growth in the real-time PCR, digital PCR, and end-point PCR Market. Advancements encompass automation, advanced thermal cycling, and integration with digital and imaging technologies, expanding applications in genomics, oncology, and infectious disease diagnostics. The dynamic evolution of PCR platforms positions the market at the forefront, delivering sophisticated molecular tools tailored to the evolving demands of precision medicine and personalized diagnostics.
Growing financial support from governments, private entities, and pharmaceutical companies is driving demand for advanced molecular diagnostic technologies. Real-time PCR, digital PCR, and end-point PCR are pivotal in genetic material analysis for life sciences research. This surge in funding not only supports the development and adoption of these PCR technologies but also fosters innovation in genomics, personalized medicine, and infectious disease research. The financial boost underscores the crucial role these PCR techniques play in advancing life sciences, promising transformative applications and breakthroughs in scientific understanding.
A surge in companion diagnostic development is driving robust growth in the market. With precision medicine gaining traction, the demand for molecular diagnostic tools, specifically PCR technologies, is escalating. Companion diagnostics, crucial in determining therapy suitability based on individual genetic profiles, heavily rely on real-time, digital, and end-point PCR for precise genetic analysis. These PCR methods aid in biomarker identification, facilitating targeted treatment approaches. The expanding landscape of companion diagnostic development, especially in oncology and personalized medicine, fuels the demand for these advanced PCR technologies.
Increased awareness of infectious diseases has heightened the demand for advanced molecular diagnostic tools. These technologies play a crucial role in swift and accurate pathogen detection, enabling prompt response measures. Governments, healthcare entities, and research institutions worldwide are heavily investing in these PCR technologies to bolster diagnostic capabilities, monitor disease spread, and facilitate timely interventions. The urgent need for robust healthcare infrastructures has led to heightened funding, fostering innovation and technological advancements in the PCR market to fortify global preparedness for public health emergencies.
Real-time PCR, Digital PCR, and End-point PCR Market Report Highlights
In 2023, the consumables & reagents segment held significant market revenue share owing to focus on point-of-care testing, and increasing adoption of precision medicine.
The quantitative segment held significant market revenue share owing to application in gene expression analysis, microbial quantification, and viral load determination.
In 2023, the clinical segment held significant revenue share owing to use in cancer diagnostics, forensic testing, and infectious disease diagnosis.
In 2023, North America region dominated the global market due to regulatory environment, government initiatives, and prevalence of chronic diseases.
The market is highly competitive owing to the existence of market players with a global presence, including Abbott, Agilent Technologies, Inc., Biocartis NV, BioMérieux SA, F. Hoffmann-La Roche Ltd, Merck KGaA, and Roche Diagnostics among others.
Polaris Market Research has segmented the Real-time PCR, Digital PCR, And End-point PCR market report based on product, technology, application, and region:
Real-time PCR, Digital PCR, and End-point PCR, Product Outlook (Revenue - USD Billion, 2019 - 2032)
Instruments
Consumables & Reagents
Software & Services
Real-time PCR, Digital PCR, and End-point PCR, Technology Outlook (Revenue - USD Billion, 2019 - 2032)
Digital
End-point
Quantitative
Real-time PCR, Digital PCR, and End-point PCR, Application Outlook (Revenue - USD Billion, 2019 - 2032)
Research
Clinical
Forensic
Others
Real-time PCR, Digital PCR, and End-point PCR, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Netherlands
Spain
Russia
Asia Pacific
Japan
China
India
Malaysia
Indonesia
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Real-time PCR, Digital PCR, and End-point PCR Market Insights
- 4.1. Real-time PCR, Digital PCR, and End-point PCR Market – Application Snapshot
- 4.2. Real-time PCR, Digital PCR, and End-point PCR Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing prevalence of infectious diseases is projected to spur the product demand
- 4.2.1.2. Advancement in molecular diagnostics
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High instrument and consumable costs
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Real-time PCR, Digital PCR, and End-point PCR Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Real-time PCR, Digital PCR, and End-point PCR Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 5.3. Instruments
- 5.3.1. Global Real-time PCR, Digital PCR, and End-point PCR Market, by Instruments, by Region, 2019-2032 (USD Billion)
- 5.4. Consumables & Reagents
- 5.4.1. Global Real-time PCR, Digital PCR, and End-point PCR Market, by Consumables & Reagents, by Region, 2019-2032 (USD Billion)
- 5.5. Software & Services
- 5.5.1. Global Real-time PCR, Digital PCR, and End-point PCR Market, by Software & Services, by Region, 2019-2032 (USD Billion)
- 6. Global Real-time PCR, Digital PCR, and End-point PCR Market, by Technology
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 6.3. Digital
- 6.3.1. Global Real-time PCR, Digital PCR, and End-point PCR Market, by Digital, by Region, 2019-2032 (USD Billion)
- 6.4. End-point
- 6.4.1. Global Real-time PCR, Digital PCR, and End-point PCR Market, by End-point, by Region, 2019-2032 (USD Billion)
- 6.5. Quantitative
- 6.5.1. Global Real-time PCR, Digital PCR, and End-point PCR Market, by Quantitative, by Region, 2019-2032 (USD Billion)
- 7. Global Real-time PCR, Digital PCR, and End-point PCR Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 7.3. Research
- 7.3.1. Global Real-time PCR, Digital PCR, and End-point PCR Market, by Research, By Region, 2019-2032 (USD Billion)
- 7.4. Clinical
- 7.4.1. Global Real-time PCR, Digital PCR, and End-point PCR Market, by Clinical, By Region, 2019-2032 (USD Billion)
- 7.5. Forensic
- 7.5.1. Global Real-time PCR, Digital PCR, and End-point PCR Market, by Forensic, By Region, 2019-2032 (USD Billion)
- 7.6. Others
- 7.6.1. Global Real-time PCR, Digital PCR, and End-point PCR Market, by Others, By Region, 2019-2032 (USD Billion)
- 8. Global Real-time PCR, Digital PCR, and End-point PCR Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Real-time PCR, Digital PCR, and End-point PCR Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Real-time PCR, Digital PCR, and End-point PCR Market – North America
- 8.3.1. North America: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.3.2. North America: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.3.3. North America: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.3.4. Real-time PCR, Digital PCR, and End-point PCR Market – U.S.
- 8.3.4.1. U.S.: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.3.5. Real-time PCR, Digital PCR, and End-point PCR Market – Canada
- 8.3.5.1. Canada: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.4. Real-time PCR, Digital PCR, and End-point PCR Market – Europe
- 8.4.1. Europe: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.4.3. Europe: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.4.4. Real-time PCR, Digital PCR, and End-point PCR Market – UK
- 8.4.4.1. UK: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.4.5. Real-time PCR, Digital PCR, and End-point PCR Market – France
- 8.4.5.1. France: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.4.5.3. France: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.4.6. Real-time PCR, Digital PCR, and End-point PCR Market – Germany
- 8.4.6.1. Germany: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.4.7. Real-time PCR, Digital PCR, and End-point PCR Market – Italy
- 8.4.7.1. Italy: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.4.8. Real-time PCR, Digital PCR, and End-point PCR Market – Spain
- 8.4.8.1. Spain: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.4.9. Real-time PCR, Digital PCR, and End-point PCR Market – Netherlands
- 8.4.9.1. Netherlands: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.4.10. Real-time PCR, Digital PCR, and End-point PCR Market – Russia
- 8.4.10.1. Russia: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.5. Real-time PCR, Digital PCR, and End-point PCR Market – Asia Pacific
- 8.5.1. Asia Pacific: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.5.4. Real-time PCR, Digital PCR, and End-point PCR Market – China
- 8.5.4.1. China: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.5.4.3. China: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.5.5. Real-time PCR, Digital PCR, and End-point PCR Market – India
- 8.5.5.1. India: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.5.5.3. India: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.5.6. Real-time PCR, Digital PCR, and End-point PCR Market – Malaysia
- 8.5.6.1. Malaysia: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.5.7. Real-time PCR, Digital PCR, and End-point PCR Market – Japan
- 8.5.7.1. Japan: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.5.8. Real-time PCR, Digital PCR, and End-point PCR Market – Indonesia
- 8.5.8.1. Indonesia: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.5.9. Real-time PCR, Digital PCR, and End-point PCR Market – South Korea
- 8.5.9.1. South Korea: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.6. Real-time PCR, Digital PCR, and End-point PCR Market – Middle East & Africa
- 8.6.1. Middle East & Africa: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.6.4. Real-time PCR, Digital PCR, and End-point PCR Market – Saudi Arabia
- 8.6.4.1. Saudi Arabia: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.6.5. Real-time PCR, Digital PCR, and End-point PCR Market – UAE
- 8.6.5.1. UAE: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.6.6. Real-time PCR, Digital PCR, and End-point PCR Market – Israel
- 8.6.6.1. Israel: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.6.7. Real-time PCR, Digital PCR, and End-point PCR Market – South Africa
- 8.6.7.1. South Africa: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.7. Real-time PCR, Digital PCR, and End-point PCR Market – Latin America
- 8.7.1. Latin America: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.7.4. Real-time PCR, Digital PCR, and End-point PCR Market – Mexico
- 8.7.4.1. Mexico: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.7.5. Real-time PCR, Digital PCR, and End-point PCR Market – Brazil
- 8.7.5.1. Brazil: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 8.7.6. Real-time PCR, Digital PCR, and End-point PCR Market – Argentina
- 8.7.6.1. Argentina: Real-time PCR, Digital PCR, and End-point PCR Market, by Product, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Real-time PCR, Digital PCR, and End-point PCR Market, by Application, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Real-time PCR, Digital PCR, and End-point PCR Market, by Technology, 2019-2032 (USD Billion)
- 9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
- 10. Company Profiles
- 10.1. Abbott
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. .Agilent Technologies, Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Analytik Jena AG
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Becton, Dickinson and Company
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Bio-Rad Laboratories, Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Biocartis NV
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. BioMérieux SA
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Danaher Corporation
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. F. Hoffmann-La Roche Ltd
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Fluidigm Corporation
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Illumina, Inc.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Merck KGaA
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Roche Diagnostics
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Takara Bio Inc.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Thermo Fisher Scientific, Inc.
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook